Through the Dren Bio deal, SNY intends to expand its immunology pipeline and establish itself as a leading immunology company ...

Carla Day was diagnosed with lupus in January 1988. After struggling and persevering with the disease for over 30 years, she ...

Now, researchers from Yale have found that a specific bacterium, called Enterococcus gallinarum, can move from the gut to ...

The FDA has agreed to review an application from Roche that seeks approval in the U.S. of obinutuzumab as a treatment for ...

Lupus is an autoimmune disease where the body's immune system attacks its own tissues and organs, causing inflammation and damaging organs. A new study has now shown that the natural active ingredient ...

The deal with startup Dren Bio hands Sanofi a so-called myeloid cell engager that would compete with an array of programs ...

Under the terms of the deal, Sanofi will pay $600 million upfront to buy an affiliate of the California-based biotech, called ...

Learning the facts about lupus can mean the difference between early treatment and serious complications that impact quality ...

Autoimmune diseases make the immune system attack healthy tissues. These can affect organs like kidneys, leading to conditions such as Lupus Nephritis and Rheumatoid Arthritis. Diagnosis can be ...

According to a 2020 study, autoimmune diseases disproportionately affect women – accounting for nearly 80 per cent of cases.

Having established success in cancer, biopharma is now looking to leverage CAR T therapies against a new target, autoimmune ...

Wedbush initiated coverage on Zenas BioPharma, Inc. (NASDAQ:ZBIO), a clinical-stage global biopharmaceutical company focused ...